Intriguingly, the decrease in dTTP pools through SHMT2 knockdown was insufficient to change the speed of DNA replication fork progression and JMF4073 sensitivity in T315I-Bcr-Abl-32D cells (Fig
Since GSH is not carried inside the cell, exogenously administered GSH is most likely to act by increasing plasma GSH levels reducing luminal oxidative stress and increasing NO bioavailability in patients with endothelial dysfunction (220)
Recently, efforts have focused on designing and developing fluorescent-based agents for disease diagnosis and treatment
Gastroenterology 156 (8), 22302241
Chen J, Muntner P, Hamm LL, et al
Over 68 weeks in the REDEFINE trials, cagrilintide 2.4 mg alone achieved approximately 10.8% body weight reduction